[Stable angina pectoris: what is the role of calcium antagonists?].
Tiberti
G
G
Divisione di Cardiologia, Ospedale di Lecco.
Bossi
M
M
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000787:Angina Pectoris / Q000188:drug therapy*; D001262:Atenolol / Q000008:administration & dosage; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004095:Dihydropyridines / Q000627:therapeutic use; D004110:Diltiazem / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015736:Felodipine / Q000627:therapeutic use; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D009543:Nifedipine / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D001262:Atenolol; D014700:Verapamil; D004110:Diltiazem; D008790:Metoprolol; D009543:Nifedipine; D015736:Felodipine